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The Americas Hepato-Pancreato-Biliary Association (AHPBA) convened its 13th Annual Meeting on
February 20–24th, 2013 in Miami Beach, Florida. This was a record-setting event for the Association, with
the highest number of registered attendees in the history of its Annual Congress, and was matched by the
high quality of original research work presented. HPB will feature the outstanding papers presented at
that Congress, with topics that span the full spectrum of HPB disease and ranging in diversity from
clinical outcomes research to cancer genomics. Some highlights in this issue include:
Tzeng et al. analyzed venous thromboembolic event (VTE) rates after hepatectomy, as reported in the
American College of Surgeons National Quality Improvement Program database. This study from MD
Anderson Cancer Center showed relatively low rates of post-hepatectomy deep vein thrombosis (1.9%),
pulmonary embolus (1.2%) and overall VTE (2.8%). Approximately 30% of VTE were diagnosed after
discharge and they identified factors associated with early and late VTE that may help guide post-
operative and post-discharge DVT prophylaxis.
Frankel and colleagues from Memorial Sloan-Kettering Cancer Center analyzed patients submitted to
pancreatic resection for non-invasive IPMN. Dysplasia at the pancreatic resection margin was shown
to be a significant and independent predictor of recurrent disease in the remnant pancreas compared to
those without dysplastic changes (31% vs. 13%). Most of the recurrent disease was in the form of benign
IPMN but 5 of the 35 patients in this group developed invasive cancer during follow up.
Using data from the Organ Procurement and Transplantation Network database, Groeschl et al. from
the Medical College of Wisconsin analyzed the viral status of 7,742 patients transplanted for HCC,
showing that hepatitis B-/C+ had higher re-transplantation rates and poorer overall survival compared
to hepatitis B+/C- and hepatitis B-/C- patients. By contrast, outcome for the small number of hepatitis
B+/C+ patients was not as poor.
In a collaborative study from Baltimore and Atlanta, Fisher and her colleagues undertook a case
comparison to determine the relative risks of right hepatectomy and right posterior sectorectomy. In the
heterogeneous group of 580 patients studied, these investigators demonstrated similar operative out-
comes but reduced risk of postoperative liver insufficiency with the parenchymal-sparing technique
supporting the philosophy of hepatic parenchymal sparing whenever possible.
The contributions to the AHPBA Annual Meeting cannot be accommodated in one single dedicated
issue and readers should look out for quality articles on EarlyView and in future issues of HPB.
Highlights that will be featured in coming issues of the journal will include the following:
Bayani et al. analyzed 95 patients with chronic pancreatitis undergoing total pancreatectomy and islet
autotransplantation in patients over a 40 month period. Eighteen patients were diabetic preoperatively;
but the authors provide evidence to support islet cell transplantation in this group since these patients
often demonstrate islet function postoperatively and have minimal increases in insulin requirements.
The impact of perioperative bevacizumab on outcome after resection of hepatic colorectal metastases
was investigated by a collaborative group from Paris and Montreal. In this study, Devaud et al. compared
patients treated with perioperative FOLFOX to a group given FOLFOX plus bevacizumab. The authors
found no differences between the two groups in terms of disease recurrence and survival, suggesting that
its use in this setting is likely of marginal benefit.
Worhunsky et al. from Stanford University retrospectively analyzed 118 patients after resection of
well-differentiated pancreatic neuroendocrine tumors and correlated the degree of arterial enhancement
on pre-resection CT with histopathologic variables and outcome. Hypoenhancing tumors more com-
monly had adverse histologic features and were associated with worse survival compared to hyper- or
iso-enhancing tumors.
A multi-institutional group,Chau et al., assessed the correlation between publicized hospital rankings
and outcome after pancreatectomy. The study exposed the significant heterogeneity among publically
available rating systems and underscored the need for further investigation to determine the critical
metrics for assessing quality outcomes.
Our Society is pleased to see the product of the successful 2013 meeting and remains fully committed
to the success and global impact of our journal, HPB.
William Jarnagin, MD
AHPBA Past-President
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